INSULIN GLARGINE AND LIXISENATIDE

INSULIN GLARGINE AND LIXISENATIDE was reported 3660 times

INSULIN GLARGINE AND LIXISENATIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE ANCHORED HEARING AID IMPLANTATION 1 0.2500
1 MEDULLARY COMPRESSION SYNDROME 1 0.0833
2 CHELATION THERAPY 1 0.0625
3 MODEL FOR END STAGE LIVER DISEASE SCORE ABNORMAL 1 0.0556
4 NON-PROLIFERATIVE RETINOPATHY 1 0.0526
5 TONGUE CANCER RECURRENT 1 0.0263
6 ALLERGY TO SURGICAL SUTURES 1 0.0233
7 PERINEAL SWELLING 1 0.0208
8 BENIGN ABDOMINAL NEOPLASM 1 0.0208
9 DEVICE OPERATIONAL ISSUE 71 0.0165
10 PERIORBITAL DISCOMFORT 1 0.0156
11 KIDNEY CONTUSION 1 0.0154
12 BILIARY CATHETER INSERTION 1 0.0149
13 PANCREATIC ENZYMES ABNORMAL 1 0.0102
14 ADMINISTRATION SITE WOUND 1 0.0101
15 PRODUCT CONTAMINATION WITH BODY FLUID 2 0.0098
16 PSYCHIATRIC EVALUATION 1 0.0085
17 CONJUNCTIVAL EROSION 1 0.0083
18 PAIN THRESHOLD DECREASED 1 0.0082
19 PRODUCT STORAGE ISSUE 30 0.0079
20 EXPOSURE VIA SKIN CONTACT 203 0.0078
21 KERATOMILEUSIS 2 0.0078
22 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 9 0.0075
23 HYPOTONIC URINARY BLADDER 1 0.0074
24 PINEAL GLAND CYST 1 0.0071
25 EXPOSURE VIA EYE CONTACT 3 0.0071
26 PRODUCT DISPENSING ISSUE 30 0.0070
27 INTERCOSTAL NEURALGIA 1 0.0056
28 GLYCOSYLATED HAEMOGLOBIN DECREASED 9 0.0056
29 POSTPRANDIAL HYPOGLYCAEMIA 1 0.0053
30 BLOOD INSULIN ABNORMAL 1 0.0053
31 GENERAL PHYSICAL CONDITION DECREASED 1 0.0053
32 SHOULDER DEFORMITY 1 0.0051
33 PSEUDOALDOSTERONISM 1 0.0051
34 SPLENIC ARTERY ANEURYSM 1 0.0048
35 PYELITIS 1 0.0048
36 LIP INFECTION 1 0.0047
37 EMPHYSEMATOUS CYSTITIS 1 0.0047
38 IMMOBILISATION SYNDROME 1 0.0047
39 PRODUCT STORAGE ERROR 402 0.0046
40 RETINAL OCCLUSIVE VASCULITIS 1 0.0045
41 LASER THERAPY 1 0.0044
42 INJECTION SITE GRANULOMA 1 0.0042
43 OESOPHAGEAL OPERATION 1 0.0039
44 BLOOD GLUCOSE ABNORMAL 71 0.0038
45 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
46 BLOOD GLUCOSE FLUCTUATION 40 0.0036
47 CAPILLARITIS 1 0.0036
48 PRODUCT TEMPERATURE EXCURSION ISSUE 18 0.0035
49 MALIGNANT NEOPLASM OF EYE 1 0.0035
50 UMBILICAL HERNIA REPAIR 1 0.0034
51 CREATININE URINE INCREASED 1 0.0033
52 ACCIDENTAL EXPOSURE TO PRODUCT 340 0.0033
53 SUBDURAL HYGROMA 1 0.0033
54 COLOUR BLINDNESS 3 0.0033
55 GASTRIC HYPOMOTILITY 1 0.0033
56 PRODUCT DISPENSING ERROR 68 0.0031
57 GENITAL INFECTION 1 0.0030
58 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
59 VASCULAR DEVICE OCCLUSION 1 0.0029
60 GLYCOSYLATED HAEMOGLOBIN INCREASED 73 0.0029
61 TENOPLASTY 1 0.0029
62 PRODUCT DOSE CONFUSION 1 0.0028
63 CARCINOID SYNDROME 1 0.0028
64 BENIGN NEOPLASM OF THYROID GLAND 2 0.0027
65 DIABETIC GASTROPARESIS 1 0.0027
66 MULTIPLE USE OF SINGLE-USE PRODUCT 15 0.0027
67 DIABETIC KETOSIS 1 0.0026
68 COLON CANCER STAGE III 1 0.0026
69 DEVICE DISPENSING ERROR 3 0.0025
70 BLOOD GLUCOSE INCREASED 467 0.0025
71 VULVAL ABSCESS 1 0.0024
72 INTESTINAL PROLAPSE 1 0.0024
73 HEARING AID USER 1 0.0023
74 INTERCEPTED PRODUCT STORAGE ERROR 8 0.0022
75 MINERAL SUPPLEMENTATION 1 0.0022
76 LAPAROTOMY 1 0.0022
77 DEVICE MECHANICAL ISSUE 29 0.0021
78 HYPERMETROPIA 2 0.0021
79 SHOCK HYPOGLYCAEMIC 1 0.0021
80 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
81 BLOOD GLUCOSE DECREASED 100 0.0021
82 GLARE 1 0.0019
83 ABDOMINAL INJURY 1 0.0019
84 DEVICE USE CONFUSION 1 0.0019
85 BINGE EATING 2 0.0019
86 MORNING SICKNESS 1 0.0018
87 BONE FRAGMENTATION 1 0.0018
88 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
89 SINUS POLYP 1 0.0017
90 NERVE BLOCK 1 0.0017
91 HYPOAESTHESIA EYE 1 0.0017
92 ENDOSCOPY 1 0.0017
93 GRUNTING 1 0.0017
94 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 78 0.0017
95 INJURY ASSOCIATED WITH DEVICE 34 0.0017
96 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
97 CORTISOL INCREASED 1 0.0016
98 OEDEMA GENITAL 1 0.0016
99 BLADDER IRRITATION 1 0.0016
100 NEUROPATHIC ARTHROPATHY 1 0.0015
101 HYPOGLYCAEMIC UNCONSCIOUSNESS 3 0.0015
102 HEAD AND NECK CANCER 1 0.0015
103 IMPAIRED GASTRIC EMPTYING 20 0.0015
104 DIABETIC ULCER 1 0.0014
105 CERVICAL RADICULOPATHY 1 0.0014
106 OVARIAN MASS 1 0.0014
107 INCORRECT DOSE ADMINISTERED BY DEVICE 35 0.0013
108 LIMB CRUSHING INJURY 1 0.0013
109 CHROMATOPSIA 1 0.0013
110 INTELLECTUAL DISABILITY 2 0.0013
111 OVARIAN NEOPLASM 1 0.0013
112 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
113 OBSTRUCTIVE PANCREATITIS 1 0.0013
114 ALLERGIC COUGH 1 0.0013
115 STOMA SITE HAEMORRHAGE 2 0.0013
116 PRODUCT PRESCRIBING ISSUE 28 0.0013
117 TOE OPERATION 1 0.0013
118 POLYPECTOMY 1 0.0013
119 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
120 KETONURIA 1 0.0012
121 ADRENAL MASS 1 0.0012
122 VISUAL IMPAIRMENT 146 0.0012
123 DIABETIC COMPLICATION 3 0.0012
124 HYPOGLYCAEMIA 57 0.0012
125 ADENOMA BENIGN 1 0.0012
126 LACK OF INJECTION SITE ROTATION 2 0.0011
127 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
128 INFUSION SITE DISCOLOURATION 1 0.0011
129 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
130 DEVICE ISSUE 99 0.0011
131 HYPOGLYCAEMIC SEIZURE 1 0.0011
132 HYPOACUSIS 46 0.0011
133 RETINAL OEDEMA 2 0.0010
134 VASCULAR GRAFT 3 0.0010
135 INJECTION SITE SCAB 1 0.0010
136 ANIMAL SCRATCH 1 0.0010
137 CORRECTIVE LENS USER 1 0.0010
138 SUDDEN HEARING LOSS 2 0.0010
139 DEVICE DEFECTIVE 17 0.0010
140 BRAIN STEM INFARCTION 1 0.0010
141 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
142 THYROID HORMONES INCREASED 1 0.0010
143 CARPAL TUNNEL DECOMPRESSION 1 0.0009
144 SINUSITIS BACTERIAL 1 0.0009
145 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
146 CLAUSTROPHOBIA 1 0.0009
147 LIPASE INCREASED 7 0.0009
148 BENIGN NEOPLASM 1 0.0009
149 CORTISOL DECREASED 1 0.0009
150 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
151 PANCREATITIS NECROTISING 2 0.0009
152 DYSLEXIA 1 0.0009
153 ORAL SURGERY 2 0.0009
154 GROIN ABSCESS 1 0.0008
155 LABILE BLOOD PRESSURE 1 0.0008
156 REFLUX GASTRITIS 1 0.0008
157 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 149 0.0008
158 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
159 AMYLASE INCREASED 3 0.0008
160 PANCREATIC DISORDER 4 0.0008
161 STERNAL FRACTURE 1 0.0008
162 BLOOD UREA DECREASED 1 0.0008
163 RETINOPATHY 3 0.0008
164 DEVICE USE ISSUE 14 0.0008
165 ENDOCRINE DISORDER 1 0.0008
166 TUMOUR PAIN 1 0.0008
167 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
168 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
169 CYSTITIS NONINFECTIVE 1 0.0007
170 EFFUSION 1 0.0007
171 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
172 JOINT INSTABILITY 1 0.0007
173 DEVICE LEAKAGE 31 0.0007
174 PERIPHERAL ARTERY OCCLUSION 1 0.0007
175 TONGUE DISCOMFORT 3 0.0007
176 NEUROENDOCRINE TUMOUR 1 0.0007
177 TRACHEOSTOMY 1 0.0007
178 FAT TISSUE INCREASED 1 0.0007
179 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
180 COCCYDYNIA 1 0.0007
181 CHOLANGIOCARCINOMA 1 0.0007
182 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
183 HIV INFECTION 2 0.0007
184 EYE OPERATION 3 0.0007
185 BACTERIAL VAGINOSIS 1 0.0006
186 INJECTION SITE HYPERSENSITIVITY 2 0.0006
187 HEPATITIS E 1 0.0006
188 INTERMITTENT CLAUDICATION 1 0.0006
189 FRUSTRATION TOLERANCE DECREASED 5 0.0006
190 METABOLIC SYNDROME 1 0.0006
191 SPINAL CORD DISORDER 1 0.0006
192 DIABETIC NEUROPATHY 3 0.0006
193 SEBORRHOEIC DERMATITIS 1 0.0006
194 HYPERGLYCAEMIA 22 0.0006
195 EXPIRED DEVICE USED 2 0.0006
196 ARTHROPOD STING 1 0.0006
197 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
198 SPINAL DEFORMITY 1 0.0006
199 INTENTIONAL PRODUCT MISUSE 52 0.0006
200 HEPATORENAL SYNDROME 1 0.0006
201 WRONG PRODUCT ADMINISTERED 4 0.0006
202 BILIARY DYSKINESIA 1 0.0006
203 FOOD AVERSION 1 0.0006
204 DIABETIC RETINOPATHY 2 0.0006
205 EXPOSURE TO SARS-COV-2 1 0.0006
206 SUDDEN CARDIAC DEATH 2 0.0006
207 LAZINESS 1 0.0006
208 INJECTION SITE OEDEMA 1 0.0006
209 CHOREA 1 0.0006
210 SPONDYLOLISTHESIS 1 0.0006
211 PRODUCT ODOUR ABNORMAL 6 0.0006
212 ROTATOR CUFF REPAIR 1 0.0006
213 PANCREATIC FAILURE 1 0.0006
214 FIBRIN D DIMER INCREASED 2 0.0006
215 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
216 PRODUCT TAMPERING 1 0.0006
217 PRODUCT DOSE OMISSION 36 0.0006
218 LIVER TRANSPLANT 2 0.0005
219 INJECTION SITE INJURY 3 0.0005
220 VITRITIS 1 0.0005
221 CATHETER PLACEMENT 1 0.0005
222 ADENOCARCINOMA OF COLON 1 0.0005
223 THROAT CLEARING 2 0.0005
224 PANCREATITIS 28 0.0005
225 FOOT FRACTURE 10 0.0005
226 COMMUNICATION DISORDER 2 0.0005
227 RHEUMATIC DISORDER 1 0.0005
228 FAECES HARD 2 0.0005
229 URINE ODOUR ABNORMAL 3 0.0005
230 COLOSTOMY 1 0.0005
231 MULTI-ORGAN DISORDER 1 0.0005
232 CATARACT OPERATION 3 0.0005
233 EYELID PAIN 1 0.0005
234 RENAL MASS 1 0.0005
235 EXPIRED PRODUCT ADMINISTERED 16 0.0005
236 INJECTION SITE DISCOLOURATION 6 0.0005
237 INJECTION SITE INDENTATION 1 0.0005
238 DIABETIC KETOACIDOSIS 11 0.0005
239 INJECTION SITE RASH 14 0.0005
240 LIGAMENT RUPTURE 2 0.0005
241 ACCIDENT AT WORK 1 0.0005
242 SPINAL COLUMN INJURY 1 0.0004
243 LARGE INTESTINAL OBSTRUCTION 1 0.0004
244 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
245 PERIARTHRITIS 1 0.0004
246 ORAL PRURITUS 1 0.0004
247 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
248 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
249 BREAKTHROUGH PAIN 1 0.0004
250 HUNGER 6 0.0004
251 NECK SURGERY 1 0.0004
252 PANCREATITIS CHRONIC 1 0.0004
253 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
254 EXTRA DOSE ADMINISTERED 17 0.0004
255 PULSE ABNORMAL 1 0.0004
256 NEEDLE ISSUE 12 0.0004
257 DENTAL OPERATION 1 0.0004
258 OFF LABEL USE 355 0.0004
259 INJECTION SITE EXTRAVASATION 5 0.0004
260 FOOT OPERATION 2 0.0004
261 RETINAL ARTERY OCCLUSION 1 0.0004
262 BRAIN ABSCESS 1 0.0004
263 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
264 DEMENTIA 11 0.0004
265 AMMONIA INCREASED 2 0.0004
266 AORTIC ARTERIOSCLEROSIS 1 0.0004
267 BLOOD CHLORIDE DECREASED 1 0.0004
268 LIPOMA 1 0.0004
269 MUCORMYCOSIS 1 0.0004
270 PRODUCT USE COMPLAINT 6 0.0004
271 GASTROINTESTINAL INJURY 1 0.0004
272 CHONDROPATHY 1 0.0004
273 ORAL FUNGAL INFECTION 1 0.0004
274 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
275 EYE DISORDER 12 0.0004
276 DIABETIC COMA 1 0.0004
277 PRODUCT LEAKAGE 2 0.0004
278 PANCREATITIS ACUTE 8 0.0004
279 NECK MASS 1 0.0004
280 SEASONAL ALLERGY 5 0.0004
281 BREAST CANCER STAGE IV 1 0.0004
282 OXYGEN SATURATION ABNORMAL 1 0.0004
283 INJECTION SITE SCAR 1 0.0004
284 TUMOUR HAEMORRHAGE 1 0.0004
285 CARDIAC OPERATION 3 0.0003
286 BLOOD MAGNESIUM DECREASED 3 0.0003
287 VOMITING PROJECTILE 1 0.0003
288 BILIARY COLIC 1 0.0003
289 PULMONARY PAIN 1 0.0003
290 PRODUCT COMMUNICATION ISSUE 3 0.0003
291 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
292 PRODUCT PRESCRIBING ERROR 8 0.0003
293 CARDIAC PACEMAKER INSERTION 2 0.0003
294 INFUSION SITE REACTION 1 0.0003
295 URINE ANALYSIS ABNORMAL 1 0.0003
296 THYROIDITIS 1 0.0003
297 LUNG ADENOCARCINOMA 1 0.0003
298 IRITIS 1 0.0003
299 DYSCHEZIA 1 0.0003
300 DIABETIC FOOT 1 0.0003
301 INTRACARDIAC THROMBUS 1 0.0003
302 FAMILY STRESS 1 0.0003
303 ILEUS 4 0.0003
304 RESPIRATORY RATE DECREASED 1 0.0003
305 BREAST CANCER RECURRENT 1 0.0003
306 STUPOR 1 0.0003
307 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
308 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
309 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
310 BACK DISORDER 5 0.0003
311 POSTURE ABNORMAL 1 0.0003
312 KIDNEY INFECTION 6 0.0003
313 BREAST ENLARGEMENT 1 0.0003
314 VITREOUS FLOATERS 3 0.0003
315 APPETITE DISORDER 2 0.0003
316 BRAIN INJURY 3 0.0003
317 DEVICE BREAKAGE 12 0.0003
318 DRY THROAT 3 0.0003
319 PUSTULAR PSORIASIS 1 0.0003
320 INJECTION SITE REACTION 20 0.0003
321 APLASIA PURE RED CELL 1 0.0003
322 CATARACT 17 0.0003
323 INJECTION SITE DISCOMFORT 3 0.0003
324 SCRATCH 3 0.0003
325 HANGOVER 1 0.0003
326 BRONCHIOLITIS 1 0.0003
327 NECROTISING FASCIITIS 1 0.0003
328 BONE EROSION 1 0.0003
329 FACIAL PARESIS 1 0.0003
330 APPENDICECTOMY 1 0.0003
331 PYODERMA GANGRENOSUM 1 0.0003
332 ACCIDENTAL UNDERDOSE 4 0.0003
333 TONGUE DISORDER 2 0.0003
334 DERMATITIS BULLOUS 2 0.0003
335 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
336 INTENTIONAL UNDERDOSE 2 0.0003
337 CEREBRAL DISORDER 2 0.0003
338 NERVE INJURY 3 0.0003
339 NEURODERMATITIS 1 0.0003
340 PULMONARY MASS 4 0.0003
341 COLON CANCER 4 0.0003
342 INCORRECT DOSE ADMINISTERED 61 0.0003
343 PARANASAL SINUS DISCOMFORT 1 0.0003
344 INJECTION SITE HAEMORRHAGE 21 0.0003
345 CHOLECYSTECTOMY 3 0.0003
346 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
347 INJECTION SITE PAIN 80 0.0003
348 ERUCTATION 5 0.0003
349 PELVIC FRACTURE 2 0.0003
350 INJECTION SITE PRURITUS 17 0.0003
351 CHOLECYSTITIS 3 0.0003
352 ACCIDENT 3 0.0003
353 OBSTRUCTION 1 0.0003
354 FUNGAL SKIN INFECTION 1 0.0002
355 PRODUCT ADMINISTRATION ERROR 5 0.0002
356 MUSCLE DISORDER 2 0.0002
357 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
358 INJECTION SITE URTICARIA 6 0.0002
359 GOITRE 1 0.0002
360 PRODUCT PREPARATION ERROR 5 0.0002
361 LEG AMPUTATION 1 0.0002
362 SPINAL STENOSIS 1 0.0002
363 DERMATITIS ALLERGIC 3 0.0002
364 SLEEP TERROR 1 0.0002
365 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
366 INJECTION SITE IRRITATION 3 0.0002
367 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
368 INJECTION SITE SWELLING 18 0.0002
369 POOR PERIPHERAL CIRCULATION 1 0.0002
370 INTRAOCULAR PRESSURE INCREASED 3 0.0002
371 TENSION HEADACHE 1 0.0002
372 CHAPPED LIPS 1 0.0002
373 URINE OUTPUT DECREASED 2 0.0002
374 INJECTION SITE BRUISING 18 0.0002
375 FACIAL PAIN 2 0.0002
376 ILEUS PARALYTIC 1 0.0002
377 BRAIN NEOPLASM MALIGNANT 1 0.0002
378 ILLNESS 23 0.0002
379 GASTROINTESTINAL DISORDER 20 0.0002
380 SNEEZING 5 0.0002
381 MENINGITIS ASEPTIC 1 0.0002
382 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
383 URINE ABNORMALITY 1 0.0002
384 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
385 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
386 RENAL FUNCTION TEST ABNORMAL 1 0.0002
387 APHONIA 3 0.0002
388 ROSACEA 1 0.0002
389 GASTRITIS EROSIVE 1 0.0002
390 FEELING OF DESPAIR 1 0.0002
391 WEIGHT INCREASED 48 0.0002
392 INTESTINAL OBSTRUCTION 8 0.0002
393 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
394 SPINAL DISORDER 2 0.0002
395 FEELING JITTERY 4 0.0002
396 GAIT INABILITY 7 0.0002
397 INCREASED APPETITE 4 0.0002
398 GLAUCOMA 4 0.0002
399 VULVOVAGINAL PAIN 1 0.0002
400 HYPOKINESIA 3 0.0002
401 INCORRECT DOSAGE ADMINISTERED 1 0.0002
402 THERAPY CHANGE 2 0.0002
403 KNEE OPERATION 2 0.0002
404 ABDOMINAL TENDERNESS 1 0.0002
405 BLOOD PRESSURE ABNORMAL 4 0.0002
406 ANEURYSM 1 0.0002
407 INJECTION SITE INFLAMMATION 1 0.0002
408 PROTEIN URINE PRESENT 1 0.0002
409 FLUID INTAKE REDUCED 1 0.0002
410 HYPOAESTHESIA ORAL 3 0.0002
411 KLEBSIELLA INFECTION 1 0.0002
412 VAGINAL DISCHARGE 2 0.0002
413 VISION BLURRED 27 0.0002
414 MOTOR DYSFUNCTION 2 0.0002
415 INSURANCE ISSUE 3 0.0002
416 NAUSEA 154 0.0002
417 PERIPHERAL VASCULAR DISORDER 1 0.0002
418 TRISMUS 1 0.0002
419 DRUG DOSE OMISSION BY DEVICE 15 0.0002
420 SENSITIVITY TO WEATHER CHANGE 1 0.0002
421 FOOD CRAVING 1 0.0002
422 POLYARTHRITIS 1 0.0002
423 INJECTION SITE MASS 7 0.0002
424 CEREBROVASCULAR ACCIDENT 32 0.0002
425 SCIATICA 3 0.0002
426 FOOD POISONING 1 0.0002
427 OVERWEIGHT 1 0.0002
428 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
429 INTESTINAL RESECTION 1 0.0002
430 ANAL ABSCESS 1 0.0002
431 GINGIVITIS 1 0.0002
432 STRESS FRACTURE 1 0.0002
433 MUSCLE TIGHTNESS 3 0.0002
434 PHARYNGITIS STREPTOCOCCAL 2 0.0002
435 HIP SURGERY 1 0.0002
436 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
437 ASPIRATION 2 0.0002
438 MULTIPLE FRACTURES 3 0.0002
439 ASTHENOPIA 1 0.0002
440 INJECTION SITE NODULE 2 0.0002
441 CARDIAC DISORDER 17 0.0002
442 PRODUCT USE ISSUE 34 0.0002
443 STREPTOCOCCAL INFECTION 1 0.0002
444 OCULAR DISCOMFORT 2 0.0002
445 PRODUCT DOSE OMISSION ISSUE 52 0.0002
446 IMPAIRED DRIVING ABILITY 2 0.0002
447 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
448 MOUTH SWELLING 1 0.0002
449 ENTEROCOLITIS 1 0.0002
450 PANCREATIC CARCINOMA 5 0.0002
451 DYSSTASIA 5 0.0002
452 HYPERTRIGLYCERIDAEMIA 1 0.0002
453 SPINAL PAIN 2 0.0002
454 COVID-19 PNEUMONIA 2 0.0002
455 PERIPHERAL SWELLING 26 0.0002
456 WEIGHT DECREASED 47 0.0002
457 VOMITING 79 0.0002
458 POLLAKIURIA 7 0.0002
459 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
460 ODYNOPHAGIA 1 0.0002
461 MACULAR DEGENERATION 2 0.0002
462 ENDOPHTHALMITIS 1 0.0002
463 THYROID CANCER 2 0.0002
464 HEPATITIS B 1 0.0002
465 INJECTION SITE VESICLES 1 0.0002
466 ABDOMINAL PAIN UPPER 34 0.0002
467 PRESYNCOPE 4 0.0002
468 MENISCUS INJURY 1 0.0002
469 LARYNGEAL OEDEMA 1 0.0002
470 COUGH 45 0.0002
471 NASAL DRYNESS 1 0.0002
472 SWELLING OF EYELID 1 0.0002
473 INFUSION SITE SWELLING 1 0.0002
474 BLEPHAROSPASM 1 0.0002
475 PHOTOPSIA 1 0.0002
476 DIABETES MELLITUS 12 0.0002
477 FOREIGN BODY SENSATION IN EYES 1 0.0002
478 TREMOR 26 0.0002
479 ANAPHYLACTIC SHOCK 4 0.0002
480 RENAL IMPAIRMENT 13 0.0002
481 RHINORRHOEA 10 0.0002
482 CARDIAC FLUTTER 1 0.0002
483 INCOHERENT 1 0.0002
484 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
485 SWELLING FACE 10 0.0002
486 DEAFNESS 4 0.0002
487 MEMORY IMPAIRMENT 21 0.0002
488 DISABILITY 3 0.0002
489 WALKING AID USER 1 0.0002
490 SARS-COV-2 TEST POSITIVE 2 0.0002
491 CORONAVIRUS INFECTION 1 0.0002
492 FUNGAL INFECTION 5 0.0001
493 EYE HAEMORRHAGE 2 0.0001
494 POST-TRAUMATIC STRESS DISORDER 1 0.0001
495 TYPE 2 DIABETES MELLITUS 5 0.0001
496 BRONCHIECTASIS 1 0.0001
497 COVID-19 26 0.0001
498 ILL-DEFINED DISORDER 9 0.0001
499 TASTE DISORDER 3 0.0001
500 BLINDNESS 6 0.0001
501 CONSTIPATION 32 0.0001
502 INFARCTION 1 0.0001
503 ORAL DISCOMFORT 2 0.0001
504 FORMICATION 1 0.0001
505 ROAD TRAFFIC ACCIDENT 6 0.0001
506 URTICARIA 24 0.0001
507 ABDOMINAL DISCOMFORT 24 0.0001
508 BURNING SENSATION 10 0.0001
509 SKIN REACTION 2 0.0001
510 PAPULE 1 0.0001
511 RETCHING 3 0.0001
512 LOSS OF CONSCIOUSNESS 18 0.0001
513 RETINAL HAEMORRHAGE 1 0.0001
514 IMPAIRED WORK ABILITY 3 0.0001
515 INTENTIONAL DOSE OMISSION 4 0.0001
516 FEAR OF INJECTION 1 0.0001
517 METASTASIS 1 0.0001
518 HYPERHIDROSIS 18 0.0001
519 ANGINA PECTORIS 4 0.0001
520 PRURITUS GENERALISED 3 0.0001
521 PANIC REACTION 1 0.0001
522 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
523 BLOOD PRESSURE INCREASED 21 0.0001
524 INJECTION SITE ERYTHEMA 17 0.0001
525 SURGERY 8 0.0001
526 ORAL DISORDER 1 0.0001
527 NASAL CONGESTION 8 0.0001
528 PRURITUS 52 0.0001
529 ARTHROPOD BITE 1 0.0001
530 NERVOUSNESS 7 0.0001
531 KETOACIDOSIS 1 0.0001
532 TENDON PAIN 1 0.0001
533 THERAPEUTIC RESPONSE DECREASED 8 0.0001
534 OSTEOPENIA 2 0.0001
535 HIP ARTHROPLASTY 2 0.0001
536 OROPHARYNGEAL PAIN 12 0.0001
537 LIMB DISCOMFORT 4 0.0001
538 ANKLE FRACTURE 2 0.0001
539 TENDONITIS 2 0.0001
540 CONCUSSION 1 0.0001
541 RASH PRURITIC 7 0.0001
542 ABDOMINAL PAIN 30 0.0001
543 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
544 HAEMORRHAGIC STROKE 1 0.0001
545 MALAISE 56 0.0001
546 FURUNCLE 1 0.0001
547 NASAL DISCOMFORT 1 0.0001
548 RESPIRATORY TRACT CONGESTION 2 0.0001
549 FEELING ABNORMAL 30 0.0001
550 DECREASED APPETITE 29 0.0001
551 UTERINE CANCER 1 0.0001
552 SENSORY LOSS 1 0.0001
553 LOCALISED INFECTION 3 0.0001
554 STENT PLACEMENT 1 0.0001
555 DIARRHOEA 80 0.0001
556 HYPERSENSITIVITY 23 0.0001
557 FIBROMYALGIA 3 0.0001
558 PSORIATIC ARTHROPATHY 5 0.0001
559 BLOOD POTASSIUM INCREASED 2 0.0001
560 DIZZINESS 61 0.0001
561 POLYURIA 1 0.0001
562 CHOLELITHIASIS 4 0.0001
563 HICCUPS 1 0.0001
564 ESCHERICHIA INFECTION 1 0.0001
565 HEMIPLEGIA 1 0.0001
566 BLOOD UREA INCREASED 2 0.0001
567 UNEVALUABLE EVENT 9 0.0001
568 HEMIPARESIS 2 0.0001
569 HYPOPHAGIA 3 0.0001
570 VITAMIN D DECREASED 1 0.0001
571 SKIN HYPERPIGMENTATION 1 0.0001
572 MUSCULOSKELETAL DISCOMFORT 2 0.0001
573 SKIN ULCER 3 0.0001
574 PSYCHOLOGICAL TRAUMA 1 0.0001
575 RASH GENERALISED 3 0.0001
576 NEUROPATHY PERIPHERAL 11 0.0001
577 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
578 RASH MACULAR 4 0.0001
579 ANHEDONIA 3 0.0001
580 AMENORRHOEA 2 0.0001
581 NASOPHARYNGITIS 21 0.0001
582 SPINAL OSTEOARTHRITIS 1 0.0001
583 TUMOUR LYSIS SYNDROME 1 0.0001
584 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
585 ANGIOEDEMA 5 0.0001
586 HEAD DISCOMFORT 2 0.0001
587 RESPIRATORY RATE INCREASED 1 0.0001
588 GOUT 2 0.0001
589 OROPHARYNGEAL DISCOMFORT 1 0.0001
590 LIMB INJURY 3 0.0001
591 RASH 48 0.0001
592 UNDERDOSE 8 0.0001
593 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
594 MUSCLE SPASMS 20 0.0001
595 SKIN DISCOLOURATION 5 0.0001
596 RETINAL DETACHMENT 1 0.0001
597 DYSURIA 4 0.0001
598 ANAPHYLACTIC REACTION 6 0.0001
599 NERVE COMPRESSION 1 0.0001
600 IRON DEFICIENCY ANAEMIA 1 0.0001
601 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
602 ARTHROPATHY 6 0.0001
603 EYE SWELLING 4 0.0001
604 HEPATIC STEATOSIS 2 0.0001
605 RENAL DISORDER 5 0.0001
606 BACTERIAL INFECTION 2 0.0001
607 FLANK PAIN 1 0.0001
608 ARTERIOSCLEROSIS 1 0.0001
609 LEUKAEMIA 1 0.0001
610 FLATULENCE 6 0.0001
611 SPUTUM DISCOLOURED 1 0.0001
612 BLOOD URINE PRESENT 2 0.0001
613 BLOOD PRESSURE DECREASED 7 0.0001
614 PRODUCT PACKAGING ISSUE 1 0.0001
615 MUSCULOSKELETAL DISORDER 2 0.0001
616 DEHYDRATION 14 0.0001
617 RECALLED PRODUCT ADMINISTERED 1 0.0001
618 POST PROCEDURAL COMPLICATION 2 0.0001
619 AFFECT LABILITY 1 0.0001
620 ATELECTASIS 1 0.0001
621 HERNIA 2 0.0001
622 DIZZINESS POSTURAL 1 0.0001
623 PARKINSONISM 1 0.0001
624 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
625 VITAMIN D DEFICIENCY 1 0.0001
626 ARTHRITIS 8 0.0001
627 HOSPICE CARE 1 0.0001
628 LIGAMENT SPRAIN 1 0.0001
629 BLADDER DISORDER 1 0.0001
630 INABILITY TO AFFORD MEDICATION 1 0.0001
631 PRESCRIBED UNDERDOSE 2 0.0001
632 BLOOD POTASSIUM DECREASED 3 0.0001
633 GAIT DISTURBANCE 19 0.0001
634 EMPHYSEMA 1 0.0001
635 FEEDING DISORDER 2 0.0001
636 EYELID PTOSIS 1 0.0001
637 FLUID RETENTION 5 0.0001
638 SLUGGISHNESS 1 0.0001
639 INITIAL INSOMNIA 1 0.0001
640 HEADACHE 61 0.0001
641 INJECTION SITE WARMTH 2 0.0001
642 INFLAMMATION 5 0.0001
643 EYE DISCHARGE 1 0.0001
644 SWELLING 9 0.0001
645 ABDOMINAL DISTENSION 10 0.0001
646 SPEECH DISORDER 5 0.0001
647 KNEE ARTHROPLASTY 2 0.0001
648 INCONTINENCE 1 0.0001
649 DEPRESSED MOOD 5 0.0001
650 SUDDEN DEATH 1 0.0001
651 SOMNOLENCE 19 0.0001
652 RENAL PAIN 1 0.0001
653 CYSTITIS 3 0.0001
654 PALPITATIONS 11 0.0001
655 BODY HEIGHT DECREASED 1 0.0001
656 DRUG INEFFECTIVE 123 0.0001
657 LIVER FUNCTION TEST INCREASED 2 0.0001
658 BREAST CANCER METASTATIC 1 0.0001
659 HOT FLUSH 7 0.0001
660 DECREASED ACTIVITY 1 0.0001
661 OESOPHAGITIS 1 0.0001
662 DYSPEPSIA 9 0.0001
663 HEART RATE INCREASED 9 0.0001
664 DRUG DOSE OMISSION 15 0.0001
665 TOOTH FRACTURE 1 0.0001
666 BACK PAIN 21 0.0001
667 LIP SWELLING 3 0.0001
668 NEOPLASM MALIGNANT 6 0.0001
669 INFLUENZA 10 0.0001
670 RASH PAPULAR 2 0.0001
671 SKIN INFECTION 1 0.0001
672 NEPHROPATHY TOXIC 1 0.0001
673 BLOOD CALCIUM DECREASED 1 0.0001
674 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
675 EYE INFECTION 1 0.0001
676 CHEST DISCOMFORT 9 0.0001
677 MYOCARDIAL ISCHAEMIA 1 0.0001
678 SINUSITIS 9 0.0001
679 MICTURITION URGENCY 1 0.0001
680 INTERNAL HAEMORRHAGE 1 0.0001
681 CARDIAC FAILURE CONGESTIVE 7 0.0001
682 NEOPLASM 1 0.0001
683 GASTRIC HAEMORRHAGE 1 0.0001
684 METASTASES TO LUNG 1 0.0001
685 ELECTROLYTE IMBALANCE 1 0.0001
686 HEART RATE DECREASED 3 0.0001
687 SLEEP DISORDER 6 0.0001
688 BACTERAEMIA 1 0.0001
689 PRODUCTIVE COUGH 4 0.0001
690 BLOOD PRESSURE FLUCTUATION 2 0.0001
691 NEURALGIA 2 0.0001
692 CONDITION AGGRAVATED 25 0.0001
693 URINARY TRACT INFECTION 14 0.0001
694 CARDIOMEGALY 1 0.0001
695 SPINAL OPERATION 1 0.0001
696 BRONCHITIS 6 0.0001
697 GENERALISED OEDEMA 1 0.0001
698 DYSGEUSIA 6 0.0001
699 SECRETION DISCHARGE 1 0.0001
700 ASTHENIA 30 0.0001
701 DYSARTHRIA 3 0.0001
702 CELLULITIS 4 0.0001
703 BRAIN OEDEMA 1 0.0001
704 HAEMATEMESIS 2 0.0001
705 CARDIOVASCULAR DISORDER 2 0.0001
706 INFUSION SITE PAIN 1 0.0001
707 UNRESPONSIVE TO STIMULI 2 0.0001
708 INJECTION SITE INDURATION 1 0.0001
709 NODULE 1 0.0001
710 BLOOD CREATININE INCREASED 5 0.0001
711 BEDRIDDEN 1 0.0001
712 DEVICE DIFFICULT TO USE 5 0.0001
713 RENAL FAILURE 10 0.0001
714 EAR INFECTION 2 0.0001
715 THROMBOSIS 6 0.0001
716 MYOCARDIAL INFARCTION 13 0.0001
717 FEAR 2 0.0001
718 JAUNDICE 2 0.0001
719 FREQUENT BOWEL MOVEMENTS 2 0.0001
720 SINUS CONGESTION 1 0.0001
721 DRY MOUTH 6 0.0001
722 THROAT TIGHTNESS 2 0.0001
723 PRODUCT TASTE ABNORMAL 1 0.0001
724 OEDEMA 4 0.0001
725 UVEITIS 1 0.0001
726 TACHYPNOEA 1 0.0001
727 HYPOAESTHESIA 11 0.0001
728 ANAEMIA 14 0.0001
729 LUNG NEOPLASM MALIGNANT 3 0.0001
730 OSTEOPOROSIS 3 0.0001
731 CORONARY ARTERY OCCLUSION 1 0.0001
732 SKIN LESION 2 0.0001
733 PERIPHERAL COLDNESS 1 0.0001
734 CONTUSION 7 0.0001
735 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
736 DIVERTICULITIS 2 0.0001
737 PROCEDURAL PAIN 2 0.0001
738 MASS 1 0.0001
739 BLISTER 4 0.0001
740 BLOOD TEST ABNORMAL 1 0.0001
741 DEVICE MALFUNCTION 5 0.0001
742 BLINDNESS UNILATERAL 1 0.0001
743 PAIN IN JAW 2 0.0001
744 DIALYSIS 1 0.0001
745 MUSCULAR WEAKNESS 8 0.0001
746 PARALYSIS 1 0.0001
747 PARAESTHESIA ORAL 1 0.0001
748 ANOSMIA 1 0.0001
749 MUSCULOSKELETAL STIFFNESS 6 0.0001
750 DYSPHONIA 4 0.0001
751 CONFUSIONAL STATE 11 0.0001
752 PAIN IN EXTREMITY 20 0.0001
753 COLITIS ULCERATIVE 3 0.0001
754 RESPIRATORY DISORDER 2 0.0001
755 EPISTAXIS 5 0.0001
756 APHASIA 2 0.0001
757 HYPERTENSION 14 0.0001
758 CORONARY ARTERY DISEASE 2 0.0001
759 ECONOMIC PROBLEM 1 0.0001
760 VERTIGO 4 0.0001
761 DISCOMFORT 4 0.0001
762 EPILEPSY 2 0.0001
763 DYSPNOEA 37 0.0001
764 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
765 THYROID DISORDER 1 0.0001
766 MENINGIOMA 1 0.0001
767 SWOLLEN TONGUE 2 0.0001
768 BRAIN FOG 1 0.0001
769 FATIGUE 49 0.0001
770 ULCER 1 0.0001
771 OBESITY 1 0.0001
772 SENSORY DISTURBANCE 1 0.0001
773 MOVEMENT DISORDER 2 0.0001
774 DRUG INTOLERANCE 6 0.0001
775 PSORIASIS 8 0.0001
776 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
777 PAIN 37 0.0001
778 CANDIDA INFECTION 1 0.0001
779 PRODUCT QUALITY ISSUE 8 0.0001
780 HEPATIC ENZYME INCREASED 4 0.0001
781 SCAR 1 0.0001
782 GASTRIC DISORDER 2 0.0001
783 PARANOIA 1 0.0001
784 JOINT SWELLING 7 0.0001
785 DELIRIUM 2 0.0001
786 OEDEMA PERIPHERAL 7 0.0001
787 SYRINGE ISSUE 1 0.0001
788 METASTASES TO LIVER 1 0.0001
789 HYPOXIA 2 0.0001
790 COLD SWEAT 1 0.0001
791 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
792 ISCHAEMIC STROKE 1 0.0001
793 GALLBLADDER DISORDER 1 0.0001
794 THERAPY INTERRUPTED 4 0.0001
795 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
796 MOBILITY DECREASED 4 0.0001
797 DISTURBANCE IN ATTENTION 3 0.0001
798 GASTROENTERITIS VIRAL 1 0.0001
799 OSTEOMYELITIS 1 0.0001
800 PELVIC PAIN 1 0.0001
801 CRYING 2 0.0001
802 TREATMENT NONCOMPLIANCE 3 0.0001
803 ACCIDENTAL OVERDOSE 2 0.0001
804 RESTLESSNESS 2 0.0001
805 FALL 18 0.0001
806 AGRANULOCYTOSIS 1 0.0001
807 SEPSIS 6 0.0001
808 NECK PAIN 3 0.0001
809 THINKING ABNORMAL 1 0.0001
810 HEPATIC FUNCTION ABNORMAL 2 0.0001
811 MIDDLE INSOMNIA 1 0.0001
812 ERYTHEMA 11 0.0001
813 OXYGEN SATURATION DECREASED 3 0.0001
814 HEPATIC CIRRHOSIS 1 0.0001
815 EYE PAIN 3 0.0001
816 PHOTOPHOBIA 1 0.0001
817 BLOOD SODIUM DECREASED 1 0.0001
818 FRACTURE 1 0.0001
819 DEPRESSION 12 0.0001
820 CHRONIC KIDNEY DISEASE 4 0.0001
821 PROTEINURIA 1 0.0001
822 SLEEP APNOEA SYNDROME 1 0.0001
823 HERPES ZOSTER 3 0.0001
824 PULMONARY FIBROSIS 1 0.0001
825 EYE IRRITATION 3 0.0001
826 LOWER LIMB FRACTURE 1 0.0001
827 ACUTE RESPIRATORY FAILURE 1 0.0001
828 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
829 PRESCRIBED OVERDOSE 1 0.0001
830 SKIN FISSURES 1 0.0001
831 SINUS DISORDER 1 0.0001
832 UPPER LIMB FRACTURE 1 0.0001
833 SPINAL FRACTURE 1 0.0000
834 IRRITABILITY 3 0.0000
835 NO ADVERSE EVENT 9 0.0000
836 PRODUCT PHYSICAL ISSUE 1 0.0000
837 PULMONARY HYPERTENSION 1 0.0000
838 HALLUCINATION, VISUAL 1 0.0000
839 OSTEOARTHRITIS 2 0.0000
840 EATING DISORDER 1 0.0000
841 JOINT INJURY 1 0.0000
842 RECTAL HAEMORRHAGE 2 0.0000
843 SKIN CANCER 1 0.0000
844 MENTAL DISORDER 2 0.0000
845 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
846 ANXIETY 13 0.0000
847 HOSPITALISATION 7 0.0000
848 LIVER DISORDER 2 0.0000
849 TOOTH DISORDER 1 0.0000
850 PULMONARY OEDEMA 2 0.0000
851 ADVERSE DRUG REACTION 4 0.0000
852 PARAESTHESIA 7 0.0000
853 TINNITUS 2 0.0000
854 HYPOKALAEMIA 2 0.0000
855 CHEST PAIN 8 0.0000
856 BREAST CANCER 4 0.0000
857 BLOOD CHOLESTEROL INCREASED 2 0.0000
858 COGNITIVE DISORDER 2 0.0000
859 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
860 OCULAR HYPERAEMIA 2 0.0000
861 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
862 EMOTIONAL DISTRESS 5 0.0000
863 MENTAL IMPAIRMENT 1 0.0000
864 CEREBRAL INFARCTION 1 0.0000
865 LUNG DISORDER 2 0.0000
866 AGEUSIA 1 0.0000
867 PNEUMONIA ASPIRATION 1 0.0000
868 SYNCOPE 4 0.0000
869 HALLUCINATION 3 0.0000
870 ACNE 3 0.0000
871 ABDOMINAL PAIN LOWER 1 0.0000
872 GASTRIC CANCER 1 0.0000
873 ACUTE KIDNEY INJURY 6 0.0000
874 HEPATITIS 1 0.0000
875 THERAPY CESSATION 2 0.0000
876 RESPIRATORY TRACT INFECTION 1 0.0000
877 HAEMORRHAGE 4 0.0000
878 SEDATION 1 0.0000
879 JOINT STIFFNESS 1 0.0000
880 GASTRITIS 1 0.0000
881 DERMATITIS ATOPIC 2 0.0000
882 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
883 INSOMNIA 10 0.0000
884 MENSTRUATION IRREGULAR 1 0.0000
885 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
886 BLOOD BILIRUBIN INCREASED 1 0.0000
887 TREATMENT FAILURE 3 0.0000
888 MEDICATION ERROR 2 0.0000
889 HAEMOPTYSIS 1 0.0000
890 TARDIVE DYSKINESIA 1 0.0000
891 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
892 MYALGIA 6 0.0000
893 HYPERSOMNIA 1 0.0000
894 LETHARGY 2 0.0000
895 PYREXIA 12 0.0000
896 SEIZURE 4 0.0000
897 INFECTION 5 0.0000
898 BONE PAIN 2 0.0000
899 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
900 CHILLS 4 0.0000
901 ASCITES 1 0.0000
902 LABORATORY TEST ABNORMAL 1 0.0000
903 DISEASE PROGRESSION 4 0.0000
904 ARTHRALGIA 14 0.0000
905 RENAL INJURY 1 0.0000
906 LACRIMATION INCREASED 1 0.0000
907 STOMATITIS 2 0.0000
908 PLEURAL EFFUSION 2 0.0000
909 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
910 EMOTIONAL DISORDER 1 0.0000
911 FEMUR FRACTURE 1 0.0000
912 NERVOUS SYSTEM DISORDER 1 0.0000
913 BONE DENSITY DECREASED 1 0.0000
914 DRUG-INDUCED LIVER INJURY 1 0.0000
915 HEAD INJURY 1 0.0000
916 MIGRAINE 3 0.0000
917 HYPOTHYROIDISM 1 0.0000
918 METABOLIC ACIDOSIS 1 0.0000
919 HIP FRACTURE 1 0.0000
920 ATRIAL FIBRILLATION 3 0.0000
921 AMNESIA 2 0.0000
922 ALOPECIA 6 0.0000
923 OSTEONECROSIS 1 0.0000
924 STAPHYLOCOCCAL INFECTION 1 0.0000
925 URINARY RETENTION 1 0.0000
926 HYPOTENSION 6 0.0000
927 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
928 HAEMOGLOBIN DECREASED 3 0.0000
929 NIGHTMARE 1 0.0000
930 DEVICE USE ERROR 1 0.0000
931 NEOPLASM PROGRESSION 1 0.0000
932 HYPERKALAEMIA 1 0.0000
933 INJURY 2 0.0000
934 PLATELET COUNT DECREASED 3 0.0000
935 CEREBRAL HAEMORRHAGE 1 0.0000
936 DRUG EFFECT INCOMPLETE 1 0.0000
937 C-REACTIVE PROTEIN INCREASED 1 0.0000
938 AGITATION 2 0.0000
939 DYSPNOEA EXERTIONAL 1 0.0000
940 RHEUMATOID ARTHRITIS 3 0.0000
941 CARDIAC FAILURE 2 0.0000
942 PNEUMONIA 8 0.0000
943 NEUTROPHIL COUNT DECREASED 1 0.0000
944 INFLUENZA LIKE ILLNESS 2 0.0000
945 CARDIAC ARREST 2 0.0000
946 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
947 SKIN EXFOLIATION 2 0.0000
948 BALANCE DISORDER 2 0.0000
949 DEVICE DISLOCATION 1 0.0000
950 SEPTIC SHOCK 1 0.0000
951 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
952 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
953 THROAT IRRITATION 1 0.0000
954 THERAPY NON-RESPONDER 1 0.0000
955 ADVERSE EVENT 2 0.0000
956 ARRHYTHMIA 1 0.0000
957 DYSPHAGIA 2 0.0000
958 PULMONARY EMBOLISM 2 0.0000
959 DISEASE RECURRENCE 1 0.0000
960 COMA 1 0.0000
961 RASH ERYTHEMATOUS 1 0.0000
962 INTERSTITIAL LUNG DISEASE 1 0.0000
963 FLUSHING 2 0.0000
964 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
965 MUSCULOSKELETAL PAIN 1 0.0000
966 DRUG INTERACTION 3 0.0000
967 DEATH 16 0.0000
968 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
969 HAEMATOCHEZIA 1 0.0000
970 HYPONATRAEMIA 1 0.0000
971 PRODUCT SUBSTITUTION ISSUE 1 0.0000
972 SUICIDE ATTEMPT 1 0.0000
973 FEELING HOT 1 0.0000
974 EXPOSURE DURING PREGNANCY 1 0.0000
975 INTENTIONAL OVERDOSE 1 0.0000
976 DEEP VEIN THROMBOSIS 1 0.0000
977 INFUSION RELATED REACTION 1 0.0000
978 DRY SKIN 2 0.0000
979 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
981 SKIN BURNING SENSATION 1 0.0000
982 RESPIRATORY FAILURE 1 0.0000
983 TOXICITY TO VARIOUS AGENTS 2 0.0000
984 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
985 SUICIDAL IDEATION 1 0.0000
986 THROMBOCYTOPENIA 1 0.0000
987 ASTHMA 1 0.0000
988 DRUG DEPENDENCE 1 0.0000